WPRIM Management System> DCMS> Clinical and Molecular Hepatology> 2015> 21> 3

Volume: 21 Issue: 3

1. Portal flow steal after liver transplantation. Page:314—317
2. Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: A case report. Page:309—313
3. A case of hepatoblastoma misdiagnosed as combined hepatocellular carcinoma and cholangiocarcinoma in an adult. Page:300—308
4. Imaging findings for intravascular large B-cell lymphoma of the liver. Page:295—299
5. Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy. Page:287—294
6. Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease. Page:279—286
7. Preference elicitation approach for measuring the willingness to pay for liver cancer treatment in Korea. Page:268—278
8. Influence of P53 on the radiotherapy response of hepatocellular carcinoma. Page:257—267
9. Comparison and analysis of the prevalence of hepatitis C virus infection by region in the Republic of Korea during 2005-2012. Page:249—256
10. Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy. Page:242—248
11. Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure. Page:232—241
12. P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma. Page:230—231
13. The mutational landscape of hepatocellular carcinoma. Page:220—229
14. Managing alcoholic liver disease. Page:212—219
15. Personalized management of cirrhosis by non-invasive tests of liver fibrosis. Page:200—211
16. From DCPD to NTCP: The long journey towards identifying a functional hepatitis B virus receptor. Page:193—199